We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

140 hedge funds and large institutions have $569M invested in Intellia Therapeutics in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 24

1.26% less ownership

Funds ownership: 93.33% → 92.06% (-1.3%)

2% less funds holding

Funds holding: 143 → 140 (-3)

15% less capital invested

Capital invested by funds: $669M → $569M (-$100M)

33% less call options, than puts

Call options by funds: $1.12M | Put options by funds: $1.67M

Holders
140
Holders Change
-3
Holders Change %
-2.1%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
46
Reduced
35
Closed
24
Calls
$1.12M
Puts
$1.67M
Net Calls
-$548K
Net Calls Change
+$567K

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$20.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.42M
3
IC
Ikarian Capital
Texas
+$2.49M
4
BlackRock
BlackRock
New York
+$1.98M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$4.09M
2
N
Nuveen
North Carolina
-$4.08M
3
AG
Artal Group
Luxembourg
-$2.93M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.67M
5
3C
361 Capital
Colorado
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
ROTUOC
26
Regents of the University of California
California
$1.36M – – –
PP
27
PDT Partners
New York
$1.26M +$237K +17,583 +21%
Goldman Sachs
28
Goldman Sachs
New York
$1.14M -$6.82K -506 -0.5%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$1.06M +$185K +13,757 +19%
EWM
30
Elmwood Wealth Management
California
$1.04M -$203K -15,066 -23%
PIM
31
Platinum Investment Management
Australia
$1.02M +$237K +17,567 +27%
UBS Group
32
UBS Group
Switzerland
$999K -$445K -33,065 -29%
Wells Fargo
33
Wells Fargo
California
$988K +$254K +18,857 +30%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$964K +$168K +12,500 +19%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$947K +$604K +44,819 +137%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$925K +$85.7K +6,358 +9%
Deutsche Bank
37
Deutsche Bank
Germany
$897K -$646K -47,940 -40%
Allianz Asset Management
38
Allianz Asset Management
Germany
$839K -$466K -34,588 -34%
SCM
39
Shelton Capital Management
Colorado
$835K +$230K +17,100 +33%
Swiss National Bank
40
Swiss National Bank
Switzerland
$801K – – –
Creative Planning
41
Creative Planning
Kansas
$777K -$274K -20,353 -24%
Neuberger Berman Group
42
Neuberger Berman Group
New York
$744K +$25.4K +1,883 +3%
CS
43
Credit Suisse
Switzerland
$739K +$267K +19,825 +49%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$730K +$68.7K +5,100 +9%
GIM
45
Granahan Investment Management
Massachusetts
$726K -$10.3K -765 -1%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$714K -$24.9K -1,852 -3%
TCM
47
Tekla Capital Management
Massachusetts
$673K – – –
AllianceBernstein
48
AllianceBernstein
Tennessee
$656K – – –
WM
49
WS Management
Florida
$602K -$33.3K -2,470 -5%
UBS AM
50
UBS AM
Illinois
$597K +$103K +7,650 +19%
1
2
3 4 5

NTLA Hedge Fund Activity: Q1 2020 in Review

140 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q1 2020, worth a combined $569M — down 15% from $669M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of NTLA and 23 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 46 added.

The largest buyer was ARK Investment Management, adding an estimated $20.2M. The largest seller was Morgan Stanley, cutting an estimated $4.09M.

  • 140 institutional investors held Intellia Therapeutics (NTLA) as of Q1 2020, down from 143 in Q4 2019.
  • Funds reported $569M of Intellia Therapeutics stock for Q1 2020, down 15% quarter-over-quarter.
  • 23 funds opened new Intellia Therapeutics positions in Q1 2020 and 24 closed out, a net change of -1 holder.
  • The largest Intellia Therapeutics buyer in Q1 2020 was ARK Investment Management, an estimated $20.2M added.
  • The largest Intellia Therapeutics seller in Q1 2020 was Morgan Stanley, an estimated $4.09M sold.

Based on aggregated 13F filings for Q1 2020.